CDHR4

gene
On this page

Also known as VLLR9392

Summary

CDHR4 (cadherin related family member 4, HGNC:34527) is a protein-coding gene on chromosome 3p21.31, encoding Cadherin-related family member 4 (A6H8M9). Cadherins are calcium-dependent cell adhesion proteins.

Predicted to enable calcium ion binding activity. Predicted to be involved in cell adhesion. Predicted to be located in membrane. Predicted to be active in plasma membrane.

Source: NCBI Gene 389118 — RefSeq curated summary.

At a glance

  • GWAS associations: 11
  • Clinical variants (ClinVar): 142 total
  • MANE Select transcript: NM_001007540

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:34527
Approved symbolCDHR4
Namecadherin related family member 4
Location3p21.31
Locus typegene with protein product
StatusApproved
AliasesVLLR9392
Ensembl geneENSG00000187492
Ensembl biotypeprotein_coding
Entrez389118

Gene structure

Transcript identifiers

Ensembl transcripts: 6 — 4 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined

ENST00000343366, ENST00000412678, ENST00000460430, ENST00000462108, ENST00000487256, ENST00000487666

RefSeq mRNA: 1 — MANE Select: NM_001007540 NM_001007540

CCDS: CCDS46829

Canonical transcript exons

ENST00000412678 — 19 exons

ExonStartEnd
ENSE000013671554979976449799873
ENSE000013681634979924749799437
ENSE000016167954979144149791468
ENSE000016295234979358349793722
ENSE000016459384979285449793074
ENSE000016466684979562849795764
ENSE000016706534979460849794701
ENSE000016783154979692249797032
ENSE000016906084979519649795379
ENSE000017418334979882649798917
ENSE000017463684979380349794006
ENSE000017535704979899449799156
ENSE000017594514979316149793311
ENSE000017729034979494749795100
ENSE000017966344979594349796046
ENSE000017969124979246849792610
ENSE000035642784979171449791801
ENSE000035932664979073249790887
ENSE000036541864979190349791959

Expression profiles

Bgee: expression breadth ubiquitous, 108 present calls, max score 99.40.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2525 / max 50.2317, expressed in 67 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
422770.138743
422780.113840

Top tissues by expression

122 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right uterine tubeUBERON:000130299.40gold quality
olfactory segment of nasal mucosaUBERON:000538691.97gold quality
fallopian tubeUBERON:000388988.96gold quality
left uterine tubeUBERON:000130379.98gold quality
right lungUBERON:000216779.14gold quality
right testisUBERON:000453478.85gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047378.51gold quality
left testisUBERON:000453377.64gold quality
testisUBERON:000047376.88gold quality
endocervixUBERON:000045871.70gold quality
lungUBERON:000204864.95gold quality
upper lobe of left lungUBERON:000895264.62gold quality
endometriumUBERON:000129561.80gold quality
right coronary arteryUBERON:000162561.25gold quality
uterine cervixUBERON:000000260.85gold quality
popliteal arteryUBERON:000225059.70gold quality
tibial arteryUBERON:000761059.66gold quality
left coronary arteryUBERON:000162659.30gold quality
thoracic aortaUBERON:000151558.93gold quality
ascending aortaUBERON:000149658.78gold quality
descending thoracic aortaUBERON:000234558.69gold quality
myometriumUBERON:000129657.16gold quality
stromal cell of endometriumCL:000225556.84gold quality
body of uterusUBERON:000985356.60gold quality
muscle layer of sigmoid colonUBERON:003580556.28gold quality
zone of skinUBERON:000001456.03gold quality
skin of legUBERON:000151155.93gold quality
skin of abdomenUBERON:000141655.86gold quality
tibial nerveUBERON:000132355.85gold quality
subcutaneous adipose tissueUBERON:000219054.46gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes11.17

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

7 targeting CDHR4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3692-3P99.9870.272139
HSA-MIR-464199.2866.64744
HSA-MIR-205499.2068.891699
HSA-MIR-365097.8864.89693
HSA-MIR-4690-3P97.0264.72981
HSA-MIR-568597.0264.341004
HSA-MIR-6856-3P96.4766.27781

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusCdhr4ENSMUSG00000032595
rattus_norvegicusCdhr4ENSRNOG00000061650

Paralogs (61): PCDHB4 (ENSG00000081818), PCDHA6 (ENSG00000081842), PCDHGA2 (ENSG00000081853), PCDHB2 (ENSG00000112852), PCDHB3 (ENSG00000113205), PCDHB5 (ENSG00000113209), PCDHB6 (ENSG00000113211), PCDHB7 (ENSG00000113212), PCDHB15 (ENSG00000113248), PCDH12 (ENSG00000113555), PCDH17 (ENSG00000118946), PCDHB8 (ENSG00000120322), PCDHB10 (ENSG00000120324), PCDHB14 (ENSG00000120327), PCDHB12 (ENSG00000120328), PCDH8 (ENSG00000136099), PCDH10 (ENSG00000138650), PCDH15 (ENSG00000150275), PCDH19 (ENSG00000165194), CDH16 (ENSG00000166589), PCDHB1 (ENSG00000171815), PCDHB9 (ENSG00000177839), PCDHB13 (ENSG00000187372), PCDH18 (ENSG00000189184), PCDHB11 (ENSG00000197479), PCDHGA1 (ENSG00000204956), PCDHA9 (ENSG00000204961), PCDHA8 (ENSG00000204962), PCDHA7 (ENSG00000204963), PCDHA5 (ENSG00000204965), PCDHA4 (ENSG00000204967), PCDHA2 (ENSG00000204969), PCDHA1 (ENSG00000204970), PCDHA13 (ENSG00000239389), PCDHGC3 (ENSG00000240184), PCDHGC5 (ENSG00000240764), PCDHGC4 (ENSG00000242419), PCDHAC2 (ENSG00000243232), PCDHAC1 (ENSG00000248383), PCDHA11 (ENSG00000249158)

Protein

Protein identifiers

Cadherin-related family member 4A6H8M9 (reviewed: A6H8M9)

Alternative names: Cadherin-like protein 29

All UniProt accessions (4): A6H8M9, E9PFE8, H7C4N6, H7C5B2

UniProt curated annotations — full annotation on UniProt →

Function. Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types.

Subcellular location. Membrane.

Isoforms (2)

UniProt IDNamesCanonical?
A6H8M9-11yes
A6H8M9-22

RefSeq proteins (1): NP_001007541* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002126Cadherin-like_domDomain
IPR015919Cadherin-like_sfHomologous_superfamily
IPR020894Cadherin_CSConserved_site
IPR050971Cadherin-domain_proteinFamily

Pfam: PF00028

UniProt features (13 total): domain 4, splice variant 2, topological domain 2, signal peptide 1, chain 1, sequence variant 1, transmembrane region 1, glycosylation site 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A6H8M9-F178.900.34

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (1): 242

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 37 (showing top): GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GOBP_CELL_CELL_ADHESION, WANG_TUMOR_INVASIVENESS_UP, GOMF_CELL_ADHESION_MOLECULE_BINDING, MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3, MIKKELSEN_NPC_ICP_WITH_H3K4ME3, chr3p21, ZBTB12_TARGET_GENES, MIR6856_3P, MIR4641, GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_DN, GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS, DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS, DESCARTES_FETAL_CEREBRUM_ASTROCYTES

GO Biological Process (2): cell adhesion (GO:0007155), homophilic cell-cell adhesion (GO:0007156)

GO Molecular Function (2): calcium ion binding (GO:0005509), cell adhesion molecule binding (GO:0050839)

GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular process1
cell-cell adhesion1
metal ion binding1
protein binding1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

316 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CDHR4IP6K1Q92551528
CDHR4RNF123Q5XPI4522
CDHR4MON1AQ86VX9496
CDHR4CDH23Q9H251483
CDHR4TRAIPQ9BWF2460
CDHR4ZACNQ401N2452
CDHR4KNCNA6PVL3432
CDHR4CDHR2Q9BYE9432
CDHR4CAMKVQ8NCB2419
CDHR4C3orf62Q6ZUJ4399
CDHR4EFCAB8A8MWE9397
CDHR4MST1RQ04912378
CDHR4R3HDM1Q15032364
CDHR4KLHL3Q9UH77363
CDHR4UCMAQ8WVF2354

IntAct

4 interactions, top by confidence:

ABTypeScore
CDHR4HSPA5psi-mi:“MI:0914”(association)0.350
CDHR4TAPBPpsi-mi:“MI:0914”(association)0.350
KLHL22TRAV18psi-mi:“MI:0914”(association)0.350

BioGRID (68): HSPA5 (Affinity Capture-MS), MRC2 (Affinity Capture-MS), COMMD9 (Affinity Capture-MS), PTPRK (Affinity Capture-MS), FBXO2 (Affinity Capture-MS), DNAJC16 (Affinity Capture-MS), COMMD3 (Affinity Capture-MS), METRNL (Affinity Capture-MS), NAGLU (Affinity Capture-MS), PON2 (Affinity Capture-MS), CNTNAP3B (Affinity Capture-MS), POLD3 (Affinity Capture-MS), ART5 (Affinity Capture-MS), SKP1 (Affinity Capture-MS), TTC37 (Affinity Capture-MS)

ESM2 similar proteins: A0A140LHF2, A6H8M9, A7LCJ3, A8E0Y8, D3YX43, D3YZF7, O14498, O15197, O70394, O70540, P01877, P0C0K6, P0C788, P0DP72, P35590, P40223, P43121, P50895, P70289, Q00657, Q06418, Q06805, Q15109, Q28173, Q5BK54, Q5NVQ6, Q5TJE4, Q61790, Q61826, Q62151, Q62230, Q63495, Q64612, Q6UVK1, Q6UWB1, Q7Z442, Q86VR7, Q8IZF5, Q8R2Y2, Q8VHY0

Diamond homologs: A6H8M9, O55134, O88338, P34616, Q5DRA2, Q5DRC0, Q5DRC3, Q5DRC4, Q5DRF3, Q91Y13, Q9NPG4, Q9Y5F6, Q9Y5H2, Q9Y5I1, B2KI42, O02840, O54800, O55075, O60330, O88278, O93319, P09803, P15116, P19534, P33146, P33148, P33151, P33152, P55280, P55284, P55285, P55286, P55287, P55288, P70407, P97291, P97326, Q03763, Q13634, Q3SWX5

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

142 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance117
Likely benign18
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2783 predictions. Top by Δscore:

VariantEffectΔscore
3:49792535:C:CTdonor_gain1.0000
3:49792852:A:ACdonor_gain1.0000
3:49792853:C:CCdonor_gain1.0000
3:49793155:CCCTA:Cdonor_loss1.0000
3:49793156:CCTAC:Cdonor_loss1.0000
3:49793157:CTAC:Cdonor_loss1.0000
3:49793158:TACCT:Tdonor_loss1.0000
3:49793308:CATC:Cacceptor_gain1.0000
3:49793310:TC:Tacceptor_gain1.0000
3:49793311:CC:Cacceptor_gain1.0000
3:49793312:C:CCacceptor_gain1.0000
3:49793312:CTGCA:Cacceptor_loss1.0000
3:49793313:T:Cacceptor_loss1.0000
3:49793802:CCG:Cdonor_gain1.0000
3:49793855:A:ACdonor_gain1.0000
3:49794606:A:ACdonor_gain1.0000
3:49794607:C:CCdonor_gain1.0000
3:49795194:A:ACdonor_gain1.0000
3:49795195:C:CCdonor_gain1.0000
3:49795195:CA:Cdonor_gain1.0000
3:49795376:TCTG:Tacceptor_loss1.0000
3:49795377:CTG:Cacceptor_gain1.0000
3:49795377:CTGC:Cacceptor_loss1.0000
3:49795378:TG:Tacceptor_gain1.0000
3:49795379:GCTGC:Gacceptor_loss1.0000
3:49795380:C:CCacceptor_gain1.0000
3:49795381:T:Gacceptor_loss1.0000
3:49795383:CA:Cacceptor_gain1.0000
3:49795384:A:ACacceptor_gain1.0000
3:49795384:A:Cacceptor_gain1.0000

AlphaMissense

5118 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
3:49793055:G:CF598L0.955
3:49793055:G:TF598L0.955
3:49793057:A:GF598L0.955
3:49795215:A:GC338R0.940
3:49793963:G:CF441L0.939
3:49793963:G:TF441L0.939
3:49793965:A:GF441L0.939
3:49795214:C:GC338S0.938
3:49795215:A:TC338S0.938
3:49793056:A:GF598S0.937
3:49793593:A:TI538N0.936
3:49793822:A:CF488L0.935
3:49793822:A:TF488L0.935
3:49793824:A:GF488L0.935
3:49795367:A:TV287D0.932
3:49795047:C:TC362Y0.924
3:49795048:A:GC362R0.923
3:49795945:G:CF236L0.921
3:49795945:G:TF236L0.921
3:49795947:A:GF236L0.921
3:49796041:G:CF204L0.919
3:49796041:G:TF204L0.919
3:49796043:A:GF204L0.919
3:49790865:A:CF778L0.918
3:49790865:A:TF778L0.918
3:49790867:A:GF778L0.918
3:49791463:A:CF763L0.916
3:49791463:A:TF763L0.916
3:49791465:A:GF763L0.916
3:49796985:G:CF181L0.913

dbSNP variants (sampled 300 via entrez): RS1000345506 (3:49792062 T>A,C), RS1001005784 (3:49802427 G>T), RS1001071331 (3:49804000 C>A), RS1001100350 (3:49797073 G>C), RS1001266151 (3:49797857 G>A), RS1001298565 (3:49797594 G>C), RS1001425750 (3:49791114 G>T), RS1001550887 (3:49798176 A>G), RS1001686683 (3:49798664 C>A), RS1001695651 (3:49791034 T>C), RS1001876928 (3:49790823 T>C), RS1002119886 (3:49803386 C>T), RS1002407139 (3:49803574 G>A,C), RS1002691548 (3:49796992 C>T), RS1003580213 (3:49802532 C>A,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (1): breast ductal adenocarcinoma (MONDO:0005590)

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

11 associations (top):

StudyTraitp-value
GCST005951_49Body mass index1.000000e-08
GCST006269_602General cognitive ability2.000000e-13
GCST006920_7Regular attendance at a gym or sports club6.000000e-10
GCST006922_9Regular attendance at a religious group3.000000e-08
GCST007044_11Extremely high intelligence4.000000e-08
GCST010002_422Refractive error4.000000e-14
GCST010698_80Subcortical volume (min-P)3.000000e-24
GCST010699_110Brain morphology (min-P)4.000000e-08
GCST010701_52Cortical surface area (MOSTest)1.000000e-16
GCST010702_36Subcortical volume (MOSTest)1.000000e-10
GCST010703_262Brain morphology (MOSTest)2.000000e-13

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0004340body mass index
EFO:0004337intelligence
EFO:0009592social interaction measurement
EFO:0004346neuroimaging measurement

MeSH disease descriptors (1)

DescriptorNameTree numbers
D018270Carcinoma, Ductal, BreastC04.557.470.200.025.232.500; C04.557.470.615.132.500; C04.588.180.390; C17.800.090.500.390

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

9 total (human), top 9 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Iincreases expression1
sodium arsenitedecreases expression1
butyraldehydedecreases expression1
Air Pollutantsincreases abundance, increases expression1
Estradiolincreases expression1
Smokeincreases abundance, increases expression1
Tobacco Smoke Pollutiondecreases expression1
Aflatoxin B1increases methylation1
Okadaic Acidincreases expression1

Clinical trials (associated diseases)

11 trials via MONDO — disease-level, not drug-specific.

TrialPhaseStatusTitle
NCT03414970PHASE3ACTIVE_NOT_RECRUITINGHypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
NCT00461344PHASE2TERMINATEDDocetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer
NCT07499999PHASE2NOT_YET_RECRUITINGRandomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer
NCT00637364PHASE1/PHASE2SUSPENDEDHigh Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain
NCT02779855PHASE1/PHASE2COMPLETEDTalimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
NCT01753908EARLY_PHASE1COMPLETEDBroccoli Sprout Extract in Treating Patients With Breast Cancer
NCT01796041EARLY_PHASE1COMPLETEDIntraoperative Imaging of Breast Cancer With Indocyanine Green
NCT01208974Not specifiedACTIVE_NOT_RECRUITINGNipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction
NCT01875198Not specifiedTERMINATEDOncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer
NCT03543397Not specifiedUNKNOWNMRI in Ductal Carcinoma in Situ (DCIS)
NCT03834532Not specifiedCOMPLETEDLiving Well After Breast Surgery

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.